This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bukoski, R. D. Articles by Wagman, D. W. Search for Related Content PubMed PubMed Citation Articles by Bukoski, R. D. Articles by Wagman, D. W.

Hypertension, Vol 16, 523-531, Copyright © 1990 by American Heart Association

ARTICLES

Injection of 1,25-(OH)2 vitamin D3 enhances resistance artery contractile properties

RD Bukoski, DB Wang and DW Wagman
Department of Medicine, Oregon Health Sciences University, Portland 97201.

The hypothesis that 1,25-dihydroxyvitamin D3 [1,25-(OH)2 vitamin D3] modulates vascular smooth muscle contractile function was tested. 1,25- (OH)2 vitamin D3 (50 ng/day) was administered by intraperitoneal injection over a 3-day period to 13-15-week-old male spontaneously hypertensive and Wistar-Kyoto normotensive rats. On the fourth day, serum was prepared and contractile force generation of isolated mesenteric resistance arteries was examined. Treatment with 1,25-(OH)2 vitamin D3 approximately doubled serum levels of the hormone and increased ionized and total serum Ca2+ and phosphate by 5-10%. No effect on blood pressure was detected. 1,25-(OH)2 vitamin D3 injection in both strains enhanced maximal stress generation to norepinephrine and serotonin by 30-40%, with no effect on apparent sensitivity of the vessels to the agonists. To assess the effect of a maneuver that elevates serum ionized Ca2+ without the addition of exogenous hormone, maximal stress generation was examined in resistance arteries isolated from rats fed diets containing 0.5% or 2% calcium over a 6-7-week period. Maximal stress generation in response to norepinephrine was greater in vessels from rats of both strains maintained on 0.5% calcium. It is concluded that 72-hour in vivo treatment with 1,25-(OH)2 vitamin D3 increases contractile force-generating capacity of resistance arteries without affecting blood pressure. It is proposed that this action of 1,25-(OH)2 vitamin D3 is the result of a direct action of the hormone on the vascular wall.

This article has been cited by other articles:

				D. C. Hatton, Q. Yue, J. Dierickx, C. Roullet, K. Otsuka, M. Watanabe, S. Coste, J. B. Roullet, T. Phanouvang, E. Orwoll, et al. Calcium metabolism and cardiovascular function after spaceflight J Appl Physiol, January 1, 2002; 92(1): 3 - 12. [Abstract] [Full Text] [PDF]

				S. G. Rostand Ultraviolet Light May Contribute to Geographic and Racial Blood Pressure Differences Hypertension, August 1, 1997; 30(2): 150 - 156. [Abstract] [Full Text]

				M. Sanchez, A. de la Sierra, A. Coca, E. Poch, V. Giner, and A. Urbano-Marquez Oral Calcium Supplementation Reduces Intraplatelet Free Calcium Concentration and Insulin Resistance in Essential Hypertensive Patients Hypertension, January 1, 1997; 29(1): 531 - 536. [Abstract] [Full Text] [PDF]

				K. Bian and R. D. Bukoski Myofilament Calcium Sensitivity of Normotensive and Hypertensive Resistance Arteries Hypertension, January 1, 1995; 25(1): 110 - 116. [Abstract] [Full Text]